Thank you, Chris. This morning, I'll focus my comments on assets under management and sales, updates to our financial reporting, adjusted net earnings and returns and our balance sheet and capital position. Starting with AUM and sales. F&G reported record AUM before flow reinsurance of $67.4 billion as of March 31 despite the near-term pressures, including retained assets under management of $54.5 billion. Compared to the first quarter of 2024, this reflects 16% and 9% increases, respectively, driven by net new business flows. F&G's gross sales were $2.9 billion, 17% lower than the first quarter of 2024, primarily due to lower MYGA sales. As we continue to prioritize allocating capital to the highest returning business, specifically indexed annuity sales and pension risk transfer sales, we intentionally scaled back MYGA. Excluding MYGA, gross sales increased 5% over the first quarter of 2024. Indexed annuity sales were strong at $1.5 billion in the first quarter, in line with the first quarter of 2024. FIA continues to be our largest contributor to indexed annuity sales, although our RILA product is gaining traction and building momentum. We took a measured approach in reflecting rate volatility in our pricing during the early part of 2025, but have subsequently seen increasing levels of submitted annuity business in March and April. Indexed universal life sales were strong at $43 million in the first quarter, in line with the first quarter of 2024. Pension risk transfer, or PRT sales, are off to a solid start with $311 million in the first quarter. While down from $584 million in the first quarter of 2024, which was a record first quarter, our full year PRT sales are typically more weighted to the back half of the year. Funding agreements were $525 million in the first quarter as compared to $105 million in the first quarter of 2024. We view funding agreement sales as opportunistic, and volumes vary quarter-to-quarter depending on market conditions. MYGA sales were $562 million in the first quarter as compared to $1.3 billion in the first quarter of 2024. F&G has the flexibility to optimize its level of flow reinsurance in line with capital targets by dynamically adjusting MYGA volumes up and down as market economics change. Net sales retained were $2.2 billion compared to $2.3 billion in the first quarter of 2024. Next, turning to our financial reporting updates. As Lisa mentioned at the top of the call, there were two retrospective management reporting changes in the quarter. First, we have refined the classification of acquisition costs between the low reinsurance fee income and cost of fund line items in our adjusted net earnings management view income statement to better align amortization and expenses. Second, significant income and expense items now exclude CLO redemptions and bond prepay income, as we consider these indicatives of the economic performance of our business. Applicable periods have been recast to conform to these changes. Importantly, there was no impact to GAAP earnings or reported ANE. Please refer to our quarterly financial supplement for further details. Also, beginning this quarter, we are presenting our financial results on an as-reported basis throughout our earnings materials. Therefore, these results, including ANE, ROA and ROE, are no longer presented on an excluding significant items basis. Turning to earnings. First quarter reported adjusted net earnings were $91 million or $0.72 per share as compared to $108 million or $0.86 per share in the first quarter of 2024. First quarter of 2025 ANE reflects a $16 million benefit from a reinsurance true-up. For the quarter, investment income from alternative investments was $63 million below management's long-term expected return. First quarter of 2024 ANE included a $2 million benefit from other income items. For the prior year quarter, investment income from alternative investments was $52 million below management's long-term expected return. Compared to the first quarter of 2024, adjusted net earnings decreased by $17 million. This was primarily driven by margin compression due to near-term headwinds, as Chris outlined, lower owned distribution margin and higher interest expense, in line with our capital market activity. These were partially offset by asset growth, higher flow reinsurance fee income and disciplined expense management. Notably, we are benefiting from increased scale as our ratio of operating expenses to AUM before flow reinsurance decreased to 58 basis points in the quarter from 63 basis points a year ago. As Chris mentioned, while we gave up some spreads during the first quarter, we believe much of that was short term in nature and not indicative of any longer-term challenge to our business model. First quarter reported adjusted return on assets was 68 basis points. ROA was pressured from near-term headwinds, as well as the short-term fluctuations in investment income from alternative investments. On a last 12-month basis, adjusted ROA of 100 basis points decreased 6 basis points from 106 basis points in the fourth quarter of 2024. And reported adjusted return on equity, excluding AOCI, was 9.7%, up 2.3% over the first quarter of 2024. Now turning to our strong and growing balance sheet. We continue to maintain RBC at or above 400%, remain committed to our long-term target of approximately 25% debt to capitalization, excluding AOCI, and expect that our balance sheet will naturally delever as shareholders' equity excluding AOCI growth. F&G has successfully completed the following recent capital markets activity as expected. In January, F&G issued $375 million of junior subordinated notes, with the net proceeds to be used for general corporate purposes, including the repayment of debt. In February, F&G fully redeemed its $300 million of outstanding senior notes due in May of 2025. On a pro forma basis, our annualized interest expense is approximately $165 million or roughly a 7% blended yield on $2.3 billion of total debt outstanding. We target holding company cash and invested assets at 2x interest coverage. In March, F&G completed the public offering of 8 million shares of common stock, with net proceeds of approximately $269 million to be used for general corporate purposes, including the support of organic growth opportunities. Fidelity National Financial, Inc., F&G's major stockholder, purchased 4.5 million shares and held an ownership stake in F&G of approximately 82% as of March 31. We ended the quarter with a GAAP book value attributable to common shareholders, excluding AOCI, of $5.8 billion or $43.31 per share at March 31. I share Chris' enthusiasm for F&G's future opportunities to deliver long-term shareholder value. As we navigate the near-term headwinds and macro uncertainty, we are focused on managing sales and in-force profitability to optimize our return on capital, diversifying our spread-based and fee-based earnings through middle market life insurance, low reinsurance and own distribution and continuing our progress towards the target set out at our 2023 Investor Day, which will continue to drive expansion of our return on equity. This concludes our prepared remarks, and let me now turn the call back to our operator for questions.